Dynasty Market Report — November 6, 2026
The Lede
Joe Milton is real. The Giants quarterback posted his second straight strong performance, forcing the dynasty market to reprice what was a near-worthless speculative asset into a legitimate SF1B conversation at DME 1,085 — a 67% single-week move that still looks undervalued if he holds the starting job. With Lamar Jackson cratering on injury concerns in Baltimore simultaneously, the QB market is reshuffling faster than any week this season.
Who's Rising
Milton's surge (+67.18%, DME 1,085) is the headliner, but don't sleep on Shedeur Sanders climbing to DME 1,219 (+46%) — Cleveland's commitment to their rookie appears real, and that number still has runway if he shows continued progress before the fantasy playoffs. Carson Beck (DME 1,425, +22.3%) benefits from the same ARI backfield momentum as Allgeier, and at that DME he's priced as a high-upside QB2; buy now before the market fully digests his role. Jonah Coleman's move to DME 2,530 (+24.9%) in Denver reflects genuine opportunity — monitor his snap share closely, because that number moves higher if he locks down the feature role.
Who's Falling
Lamar Jackson at DME 6,353 (-18%) after a loss tied to QB injuries is the most critical sell/hold decision on the board — his dynasty floor remains elite, but if the injury is meaningful, there's more downside here before stabilization. Kyler Murray (DME 2,240, -14.8%) and Derrick Henry (DME 2,266, -16.7%) are both landing in Minnesota-adjacent situations that look increasingly bleak; these are real declines, not buy-low windows, until the Vikings clarify their direction at QB. DK Metcalf (DME 1,386, -15.8%) deserves a harder look — Pittsburgh's offense clearly hasn't fixed his target environment.
The Move
Sell Derrick Henry (DME 2,266) today. His value is propped up by name recognition while his underlying situation — a struggling Minnesota offense, age, and a minus-14.8% drop in Kyler Murray's own DME this week — points to compounding decline. Flip that asset into Jonah Coleman (DME 2,530) while his price is still moving and the opportunity cost is minimal.